Desensitization With Imlifidase for HLA-Incompatible Deceased Donor Kidney Transplantation: A Delphi International Expert Consensus

Highly sensitized (HS) patients in need of kidney transplantation (KTx) typically spend a longer time waiting for compatible kidneys, are unlikely to receive an organ offer, and are at increased risk of antibody-mediated rejection (AMR). Desensitization using imlifidase, which is more rapid and remo...

Full description

Saved in:
Bibliographic Details
Main Authors: Lucrezia Furian, Uwe Heemann, Mats Bengtsson, Oriol Bestard, Isabelle Binet, Georg A. Böhmig, John Boletis, David Briggs, Frans H. J. Claas, Lionel Couzi, Emanuele Cozzi, Marta Crespo, Aiko P. J. De Vries, Fritz Diekmann, Magdalena Durlik, Denis Glotz, Ilkka Helantera, Annette Jackson, Stanley C. Jordan, Dirk Kuypers, Carmen Lefaucheur, Christophe Legendre, Tomas Lorant, Umberto Maggiore, Nizam Mamode, Smaragdi Marinaki, Annick Massart, Thomas Müller, Rainer Oberbauer, Lutz Renders, Dave Roelen, Jean-Luc Taupin, Ondřej Viklický, Angeliki Vittoraki, Annelies E. de Weerd, Maarten Naesens
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-01-01
Series:Transplant International
Subjects:
Online Access:https://www.frontierspartnerships.org/articles/10.3389/ti.2024.13886/full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1841546893885177856
author Lucrezia Furian
Uwe Heemann
Mats Bengtsson
Oriol Bestard
Isabelle Binet
Georg A. Böhmig
John Boletis
David Briggs
Frans H. J. Claas
Lionel Couzi
Emanuele Cozzi
Marta Crespo
Aiko P. J. De Vries
Fritz Diekmann
Magdalena Durlik
Denis Glotz
Ilkka Helantera
Annette Jackson
Stanley C. Jordan
Dirk Kuypers
Dirk Kuypers
Carmen Lefaucheur
Christophe Legendre
Tomas Lorant
Umberto Maggiore
Nizam Mamode
Smaragdi Marinaki
Annick Massart
Thomas Müller
Rainer Oberbauer
Lutz Renders
Dave Roelen
Jean-Luc Taupin
Ondřej Viklický
Angeliki Vittoraki
Annelies E. de Weerd
Maarten Naesens
author_facet Lucrezia Furian
Uwe Heemann
Mats Bengtsson
Oriol Bestard
Isabelle Binet
Georg A. Böhmig
John Boletis
David Briggs
Frans H. J. Claas
Lionel Couzi
Emanuele Cozzi
Marta Crespo
Aiko P. J. De Vries
Fritz Diekmann
Magdalena Durlik
Denis Glotz
Ilkka Helantera
Annette Jackson
Stanley C. Jordan
Dirk Kuypers
Dirk Kuypers
Carmen Lefaucheur
Christophe Legendre
Tomas Lorant
Umberto Maggiore
Nizam Mamode
Smaragdi Marinaki
Annick Massart
Thomas Müller
Rainer Oberbauer
Lutz Renders
Dave Roelen
Jean-Luc Taupin
Ondřej Viklický
Angeliki Vittoraki
Annelies E. de Weerd
Maarten Naesens
author_sort Lucrezia Furian
collection DOAJ
description Highly sensitized (HS) patients in need of kidney transplantation (KTx) typically spend a longer time waiting for compatible kidneys, are unlikely to receive an organ offer, and are at increased risk of antibody-mediated rejection (AMR). Desensitization using imlifidase, which is more rapid and removes total body immunoglobulin G (IgG) to a greater extent than other methods, enables transplantation to occur between HLA-incompatible (HLAi) donor–recipient pairs and allows patients to have greater access to KTx. However, when the project was launched there was limited data and clinical experience with desensitization in general and with imlifidase specifically. Hence, this Delphi methodology was used to reach a consensus from a multi-disciplinary team (MDT) of experts from 15 countries on the management of HS patients undergoing imlifidase HLAi from a deceased donor (DD) KTx. This Delphi consensus provides clinical practice guidance on the use of imlifidase in the end-to-end management of HS patients undergoing an HLAi DD KTx and supports centers in the development of guidelines for the utilization and integration of imlifidase into clinical practice.
format Article
id doaj-art-7a7e636d154148be84ffb8f31a6b03fc
institution Kabale University
issn 1432-2277
language English
publishDate 2025-01-01
publisher Frontiers Media S.A.
record_format Article
series Transplant International
spelling doaj-art-7a7e636d154148be84ffb8f31a6b03fc2025-01-10T15:42:35ZengFrontiers Media S.A.Transplant International1432-22772025-01-013710.3389/ti.2024.1388613886Desensitization With Imlifidase for HLA-Incompatible Deceased Donor Kidney Transplantation: A Delphi International Expert ConsensusLucrezia Furian0Uwe Heemann1Mats Bengtsson2Oriol Bestard3Isabelle Binet4Georg A. Böhmig5John Boletis6David Briggs7Frans H. J. Claas8Lionel Couzi9Emanuele Cozzi10Marta Crespo11Aiko P. J. De Vries12Fritz Diekmann13Magdalena Durlik14Denis Glotz15Ilkka Helantera16Annette Jackson17Stanley C. Jordan18Dirk Kuypers19Dirk Kuypers20Carmen Lefaucheur21Christophe Legendre22Tomas Lorant23Umberto Maggiore24Nizam Mamode25Smaragdi Marinaki26Annick Massart27Thomas Müller28Rainer Oberbauer29Lutz Renders30Dave Roelen31Jean-Luc Taupin32Ondřej Viklický33Angeliki Vittoraki34Annelies E. de Weerd35Maarten Naesens36Kidney and Pancreas Transplantation Unit, Department of Surgery, Oncology and Gastroenterology DISCOG, University Hospital of Padova, Padova, ItalyAbteilung für Nephrologie, Klinikum Rechts der Isar, Technische Universität München, Munich, GermanyDepartment of Immunology, Genetics and Pathology, Uppsala University, Uppsala, SwedenNephrology and Kidney Transplant Department, Vall d’Hebron University Hospital, Barcelona, SpainClinic of Nephrology and Transplantation Medicine, Cantonal Hospital St Gallen, St. Gallen, SwitzerlandDivision of Nephrology and Dialysis, Department of Medicine III, Medical University Vienna, Vienna, AustriaDepartment of Nephrology and Renal Transplantation, National and Kapodistrian University of Athens, Laiko Hospital, Athens, GreeceHistocompatibility and Immunogenetics Laboratory, Birmingham Centre, NHS Blood and Transplant, UK NHS Blood and Transplant, Birmingham, United KingdomEurotransplant Reference Laboratory, Department of Immunohaematology and Blood Transfusion, Leiden University Medical Center, Albinusdreef, Netherlands0Department of Nephrology, Transplantation, Dialysis and Apheresis, Bordeaux University Hospital, Bordeaux, France1Transplant Immunology Unit, Department of Cardiac, National Transplant Centre (CNT), Thoracic and Vascular Sciences Padua University Hospital - Ospedale Giustinianeo, Padova, Italy2Department of Nephrology, Hospital del Mar, Nephropathies Research Group, Hospital del Mar Research Institute, Barcelona, Spain3Division of Nephrology, Department of Medicine, and Leiden Transplant Center, Leiden University Medical Center, Leiden, Netherlands4Department of Nephrology and Kidney Transplantation, Hospital Clínic Barcelona, Barcelona, Spain5Klinika Transplantologii, Immunologii, Nefrologii i Chorób Wewnętrznych Warszawski Uniwersytet Medyczny ul, Warszawa, Poland6Department of Nephrology and Renal Transplantation, Saint-Louis Hospital in Paris, Paris, France7Transplantation and Liver Surgery, Helsinki University Hospital and University of Helsinki, Helsinki, Finland8Department of Surgery, Duke University, Durham, NC, United States9Nephrology and Transplant Immunology Medical Director Kidney Transplant Program Cedars-Sinai Medical Center, Pediatrics and Medicine David Geffen School of Medicine at UCLA, Los Angeles, CA, United States0Department of Nephrology and Renal Transplantation, University Hospitals Leuven, Leuven, Belgium1Department of Microbiology, Immunology and Transplantation, KU Leuven, Leuven, Belgium2Nephrologist and Head of the Nephrology and Kidney Transplantation Department, Saint-Louis Hospital-APHP, Paris, France3Nephrology at Université Paris Cité and Head of Nephrology and Transplantation Unit at Necker Hospital in Paris, Paris, France4Uppsala University, Department of Surgical Sciences, Section of Transplant Surgery, Uppsala, Sweden5Dipartimento di Medicina e Chirurgia, Università di Parma, UO Nefrologia - Trapianti Rene Pancreas, Programma Regionale Trapianti Emilia-Romagna, Azienda Ospedaliero-Universitaria di Parma, Parma, Italy6Department of Transplantation, Transplant Surgery at Guy’s and Great Ormond Street Hospitals, London, United Kingdom7National and Kapodistrian University of Athens, Clinic of Nephrology and Transplantation, “Laiko” General Hospital, Athens, Greece8Department of Nephrology, UZ Antwerpen, Antwerpen, Belgium9Clinic for Nephrology, Renal Transplant Program, Transplant Institute, University Hospital Zurich, Zurich, Switzerland0Medical University of Vienna, Vienna, Austria1Department of Nephrology of Technische Universität München, München (TUM), Munich, Germany2Department of Immunology, Leiden University Medical Center, Leiden, Netherlands3Laboratory of Immunology and Histocompatibility, Hôpital Saint-Louis, APHP Paris, Paris, France4Department of Nephrology, Institute for Clinical and Experimental Medicine, Prague, Czechia5Immunology Department and National Tissue Typing Center, “G.Gennimatas” Hospital, Athens, Greece6Erasmus MC Transplant Institute, Department of Internal Medicine, University Medical Center, Rotterdam, Netherlands1Department of Microbiology, Immunology and Transplantation, KU Leuven, Leuven, BelgiumHighly sensitized (HS) patients in need of kidney transplantation (KTx) typically spend a longer time waiting for compatible kidneys, are unlikely to receive an organ offer, and are at increased risk of antibody-mediated rejection (AMR). Desensitization using imlifidase, which is more rapid and removes total body immunoglobulin G (IgG) to a greater extent than other methods, enables transplantation to occur between HLA-incompatible (HLAi) donor–recipient pairs and allows patients to have greater access to KTx. However, when the project was launched there was limited data and clinical experience with desensitization in general and with imlifidase specifically. Hence, this Delphi methodology was used to reach a consensus from a multi-disciplinary team (MDT) of experts from 15 countries on the management of HS patients undergoing imlifidase HLAi from a deceased donor (DD) KTx. This Delphi consensus provides clinical practice guidance on the use of imlifidase in the end-to-end management of HS patients undergoing an HLAi DD KTx and supports centers in the development of guidelines for the utilization and integration of imlifidase into clinical practice.https://www.frontierspartnerships.org/articles/10.3389/ti.2024.13886/fulldesensitizationHLA incompatibleHLAikidney transplantationimlifidase
spellingShingle Lucrezia Furian
Uwe Heemann
Mats Bengtsson
Oriol Bestard
Isabelle Binet
Georg A. Böhmig
John Boletis
David Briggs
Frans H. J. Claas
Lionel Couzi
Emanuele Cozzi
Marta Crespo
Aiko P. J. De Vries
Fritz Diekmann
Magdalena Durlik
Denis Glotz
Ilkka Helantera
Annette Jackson
Stanley C. Jordan
Dirk Kuypers
Dirk Kuypers
Carmen Lefaucheur
Christophe Legendre
Tomas Lorant
Umberto Maggiore
Nizam Mamode
Smaragdi Marinaki
Annick Massart
Thomas Müller
Rainer Oberbauer
Lutz Renders
Dave Roelen
Jean-Luc Taupin
Ondřej Viklický
Angeliki Vittoraki
Annelies E. de Weerd
Maarten Naesens
Desensitization With Imlifidase for HLA-Incompatible Deceased Donor Kidney Transplantation: A Delphi International Expert Consensus
Transplant International
desensitization
HLA incompatible
HLAi
kidney transplantation
imlifidase
title Desensitization With Imlifidase for HLA-Incompatible Deceased Donor Kidney Transplantation: A Delphi International Expert Consensus
title_full Desensitization With Imlifidase for HLA-Incompatible Deceased Donor Kidney Transplantation: A Delphi International Expert Consensus
title_fullStr Desensitization With Imlifidase for HLA-Incompatible Deceased Donor Kidney Transplantation: A Delphi International Expert Consensus
title_full_unstemmed Desensitization With Imlifidase for HLA-Incompatible Deceased Donor Kidney Transplantation: A Delphi International Expert Consensus
title_short Desensitization With Imlifidase for HLA-Incompatible Deceased Donor Kidney Transplantation: A Delphi International Expert Consensus
title_sort desensitization with imlifidase for hla incompatible deceased donor kidney transplantation a delphi international expert consensus
topic desensitization
HLA incompatible
HLAi
kidney transplantation
imlifidase
url https://www.frontierspartnerships.org/articles/10.3389/ti.2024.13886/full
work_keys_str_mv AT lucreziafurian desensitizationwithimlifidaseforhlaincompatibledeceaseddonorkidneytransplantationadelphiinternationalexpertconsensus
AT uweheemann desensitizationwithimlifidaseforhlaincompatibledeceaseddonorkidneytransplantationadelphiinternationalexpertconsensus
AT matsbengtsson desensitizationwithimlifidaseforhlaincompatibledeceaseddonorkidneytransplantationadelphiinternationalexpertconsensus
AT oriolbestard desensitizationwithimlifidaseforhlaincompatibledeceaseddonorkidneytransplantationadelphiinternationalexpertconsensus
AT isabellebinet desensitizationwithimlifidaseforhlaincompatibledeceaseddonorkidneytransplantationadelphiinternationalexpertconsensus
AT georgabohmig desensitizationwithimlifidaseforhlaincompatibledeceaseddonorkidneytransplantationadelphiinternationalexpertconsensus
AT johnboletis desensitizationwithimlifidaseforhlaincompatibledeceaseddonorkidneytransplantationadelphiinternationalexpertconsensus
AT davidbriggs desensitizationwithimlifidaseforhlaincompatibledeceaseddonorkidneytransplantationadelphiinternationalexpertconsensus
AT franshjclaas desensitizationwithimlifidaseforhlaincompatibledeceaseddonorkidneytransplantationadelphiinternationalexpertconsensus
AT lionelcouzi desensitizationwithimlifidaseforhlaincompatibledeceaseddonorkidneytransplantationadelphiinternationalexpertconsensus
AT emanuelecozzi desensitizationwithimlifidaseforhlaincompatibledeceaseddonorkidneytransplantationadelphiinternationalexpertconsensus
AT martacrespo desensitizationwithimlifidaseforhlaincompatibledeceaseddonorkidneytransplantationadelphiinternationalexpertconsensus
AT aikopjdevries desensitizationwithimlifidaseforhlaincompatibledeceaseddonorkidneytransplantationadelphiinternationalexpertconsensus
AT fritzdiekmann desensitizationwithimlifidaseforhlaincompatibledeceaseddonorkidneytransplantationadelphiinternationalexpertconsensus
AT magdalenadurlik desensitizationwithimlifidaseforhlaincompatibledeceaseddonorkidneytransplantationadelphiinternationalexpertconsensus
AT denisglotz desensitizationwithimlifidaseforhlaincompatibledeceaseddonorkidneytransplantationadelphiinternationalexpertconsensus
AT ilkkahelantera desensitizationwithimlifidaseforhlaincompatibledeceaseddonorkidneytransplantationadelphiinternationalexpertconsensus
AT annettejackson desensitizationwithimlifidaseforhlaincompatibledeceaseddonorkidneytransplantationadelphiinternationalexpertconsensus
AT stanleycjordan desensitizationwithimlifidaseforhlaincompatibledeceaseddonorkidneytransplantationadelphiinternationalexpertconsensus
AT dirkkuypers desensitizationwithimlifidaseforhlaincompatibledeceaseddonorkidneytransplantationadelphiinternationalexpertconsensus
AT dirkkuypers desensitizationwithimlifidaseforhlaincompatibledeceaseddonorkidneytransplantationadelphiinternationalexpertconsensus
AT carmenlefaucheur desensitizationwithimlifidaseforhlaincompatibledeceaseddonorkidneytransplantationadelphiinternationalexpertconsensus
AT christophelegendre desensitizationwithimlifidaseforhlaincompatibledeceaseddonorkidneytransplantationadelphiinternationalexpertconsensus
AT tomaslorant desensitizationwithimlifidaseforhlaincompatibledeceaseddonorkidneytransplantationadelphiinternationalexpertconsensus
AT umbertomaggiore desensitizationwithimlifidaseforhlaincompatibledeceaseddonorkidneytransplantationadelphiinternationalexpertconsensus
AT nizammamode desensitizationwithimlifidaseforhlaincompatibledeceaseddonorkidneytransplantationadelphiinternationalexpertconsensus
AT smaragdimarinaki desensitizationwithimlifidaseforhlaincompatibledeceaseddonorkidneytransplantationadelphiinternationalexpertconsensus
AT annickmassart desensitizationwithimlifidaseforhlaincompatibledeceaseddonorkidneytransplantationadelphiinternationalexpertconsensus
AT thomasmuller desensitizationwithimlifidaseforhlaincompatibledeceaseddonorkidneytransplantationadelphiinternationalexpertconsensus
AT raineroberbauer desensitizationwithimlifidaseforhlaincompatibledeceaseddonorkidneytransplantationadelphiinternationalexpertconsensus
AT lutzrenders desensitizationwithimlifidaseforhlaincompatibledeceaseddonorkidneytransplantationadelphiinternationalexpertconsensus
AT daveroelen desensitizationwithimlifidaseforhlaincompatibledeceaseddonorkidneytransplantationadelphiinternationalexpertconsensus
AT jeanluctaupin desensitizationwithimlifidaseforhlaincompatibledeceaseddonorkidneytransplantationadelphiinternationalexpertconsensus
AT ondrejviklicky desensitizationwithimlifidaseforhlaincompatibledeceaseddonorkidneytransplantationadelphiinternationalexpertconsensus
AT angelikivittoraki desensitizationwithimlifidaseforhlaincompatibledeceaseddonorkidneytransplantationadelphiinternationalexpertconsensus
AT anneliesedeweerd desensitizationwithimlifidaseforhlaincompatibledeceaseddonorkidneytransplantationadelphiinternationalexpertconsensus
AT maartennaesens desensitizationwithimlifidaseforhlaincompatibledeceaseddonorkidneytransplantationadelphiinternationalexpertconsensus